1 / 7

Advanced Allergen Diagnosis Methods for Tailored Treatment

Explore the use of recombinant allergens for patient sensitization profiling and differential diagnosis. Learn how to identify major allergens like rPhl p.1+5 and rBet v.1 to enable targeted allergy treatment. Discover validated immunotherapy strategies.

loan
Download Presentation

Advanced Allergen Diagnosis Methods for Tailored Treatment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Un complément à l’allergo

  2. Dosages aujourd’hui

  3. Profil de sensibilisation du patient

  4. Diagnostic différentiel • Période polliniques superposables • Graminées – Bouleau • Bouleau – Frênes Utilisation des recombinants pour reconnaître l’allergène majeur : rPhl p 1+5, rBet v 1, nOle e 1 Permet d’instaurer une ITS ciblée

  5. 1000 • 1000 • rAsp f 6 • rAsp f 4 • 100 • 100 IgE Specifiques [EU/ml] IgE Specifiques [EU/ml] • 10 • 10 • 1 • 1 avec sans avec sans Contrôle Contrôle ABPA ABPA ABPA ABPA Patients sensibilisés Patients sensibilisés Diagnostic différentiel/Aspergillose bronchopulmonaire Allergique • Ref., Crameri et al., Int Immunol 1998; 10 (8): 1211-6

  6. Allergie IgE-médiée confirmée à la source allergénique (Clinique + tests cutanés + biologie source allergénique) BOULEAU CHAT GRAMINEES PARIETAIRE Indication à la mise en place d’une immunothérapie spécifique Les produits de désensibilisation ont une concentration garantie en allergènes majeurs . rBet v1 rFeld d 1 rPhl p 1 + rPhl p 5 rPar j 2 Allergènes recombinantsImmunothérapie spécifique

More Related